BR112013027123A2 - método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células - Google Patents
método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de célulasInfo
- Publication number
- BR112013027123A2 BR112013027123A2 BR112013027123A BR112013027123A BR112013027123A2 BR 112013027123 A2 BR112013027123 A2 BR 112013027123A2 BR 112013027123 A BR112013027123 A BR 112013027123A BR 112013027123 A BR112013027123 A BR 112013027123A BR 112013027123 A2 BR112013027123 A2 BR 112013027123A2
- Authority
- BR
- Brazil
- Prior art keywords
- cluster
- cell
- profile data
- analysis method
- analyzing tissue
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
- G06F18/211—Selection of the most significant subset of features
- G06F18/2115—Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V10/00—Arrangements for image or video recognition or understanding
- G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
- G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
- G06V10/771—Feature selection, e.g. selecting representative features from a multi-dimensional feature space
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
- G06V20/698—Matching; Classification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Theoretical Computer Science (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Evolutionary Computation (AREA)
- Multimedia (AREA)
- Artificial Intelligence (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Computing Systems (AREA)
- Oncology (AREA)
- Software Systems (AREA)
- Databases & Information Systems (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Image Processing (AREA)
Abstract
método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células um conjunto de dados de dados de perfil celular é armazenado. os dados de perfil celular incluem dados de imagem biométrica multiplexada descrevendo a expressão de uma pluralidade de biomarcadores. dados do perfil celular são gerados a partir de amostras de tecidos retiradas de uma coorte de pacientes tendo uma avaliação relativa aos comuns. múltiplos conjuntos de agrupamentos de células similares são gerados a partir do conjunto de dados; a proporção de células em cada agrupamento é examinada para uma associação com um diagnóstico, um prognóstico, ou uma resposta; e uma conjunto preditivo de agrupamento é selecionado com base no desempenho do modelo. um conjunto preditivo de agrupamento é selecionado com base em uma comparação entre o desempenho de, pelo menos, um modelo de um da pluralidade de conjuntos de agrupamentos. as técnicas de exibição que auxiliam na compreensão das características de um agrupamento são descritas.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161478224P | 2011-04-22 | 2011-04-22 | |
US13/252,080 US20120271553A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with clusters |
US13/252,072 US20120269418A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with clusters |
US13/252,078 US20120269419A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with moments |
US13/252,069 US20120270752A1 (en) | 2011-04-22 | 2011-10-03 | Analyzing the expression of biomarkers in cells with moments |
PCT/EP2012/057395 WO2012143562A2 (en) | 2011-04-22 | 2012-04-23 | Analyzing the expression of biomarkers in cells with clusters |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013027123A2 true BR112013027123A2 (pt) | 2017-01-10 |
Family
ID=47021377
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013027125A BR112013027125A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido, e, kit |
BR112013027122A BR112013027122A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido, e, kit |
BR112013027123A BR112013027123A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células |
BR112013027124A BR112013027124A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013027125A BR112013027125A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido, e, kit |
BR112013027122A BR112013027122A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido, e, kit |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013027124A BR112013027124A2 (pt) | 2011-04-22 | 2012-04-23 | método e sistema para analisar características de tecido |
Country Status (8)
Country | Link |
---|---|
US (5) | US20120269419A1 (pt) |
EP (4) | EP2700036A2 (pt) |
JP (4) | JP6063446B2 (pt) |
BR (4) | BR112013027125A2 (pt) |
CA (4) | CA2833428A1 (pt) |
RU (3) | RU2013145154A (pt) |
SG (4) | SG194592A1 (pt) |
WO (4) | WO2012143561A2 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201111594D0 (en) * | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
US9836865B2 (en) | 2012-12-06 | 2017-12-05 | Ge Healthcare Biosciences Corp. | Systems and methods for split screen display of biological specimen and for capturing records thereof |
US9488639B2 (en) * | 2013-02-25 | 2016-11-08 | Flagship Biosciences, Inc. | Cell-based tissue analysis |
US8995740B2 (en) * | 2013-04-17 | 2015-03-31 | General Electric Company | System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue |
CA2916520A1 (en) * | 2013-07-03 | 2015-01-08 | Coyne Ip Holdings, Llc | Methods for predicting responses to chemical or biologic substances |
US9322051B2 (en) | 2013-10-07 | 2016-04-26 | General Electric Company | Probing of biological samples |
US9298968B1 (en) * | 2014-09-12 | 2016-03-29 | Flagship Biosciences, Inc. | Digital image analysis of inflammatory cells and mediators of inflammation |
JP6791598B2 (ja) * | 2015-01-22 | 2020-11-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 異なる細胞サブセットの比率の決定方法およびシステム |
US10672505B2 (en) | 2015-06-03 | 2020-06-02 | General Electric Company | Biological data annotation and visualization |
US9953133B2 (en) | 2015-06-03 | 2018-04-24 | General Electric Company | Biological data annotation and visualization |
WO2017109860A1 (ja) * | 2015-12-22 | 2017-06-29 | 株式会社ニコン | 画像処理装置 |
US20180032681A1 (en) * | 2016-07-29 | 2018-02-01 | General Electric Company | Biological feature analysis technique |
JP6985684B2 (ja) * | 2017-02-16 | 2021-12-22 | 国立大学法人京都大学 | 細胞評価方法、細胞評価装置、及び細胞評価プログラム |
US10242473B2 (en) * | 2017-03-22 | 2019-03-26 | Sas Institute Inc. | Computer system to generate scalable plots using clustering |
WO2018201072A2 (en) * | 2017-04-28 | 2018-11-01 | 4D Path Inc. | Apparatus, systems, and methods for rapid cancer detection |
KR101990430B1 (ko) * | 2017-06-22 | 2019-06-18 | 한국과학기술원 | 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법 |
US10706328B2 (en) * | 2018-05-07 | 2020-07-07 | Google Llc | Focus-weighted, machine learning disease classifier error prediction for microscope slide images |
US10971255B2 (en) * | 2018-09-14 | 2021-04-06 | Zasti Inc. | Multimodal learning framework for analysis of clinical trials |
US11101043B2 (en) | 2018-09-24 | 2021-08-24 | Zasti Inc. | Hybrid analysis framework for prediction of outcomes in clinical trials |
AU2019385818A1 (en) * | 2018-11-29 | 2021-07-08 | Somalogic Operating Co., Inc. | Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis |
US11128667B2 (en) * | 2018-11-29 | 2021-09-21 | Rapid7, Inc. | Cluster detection and elimination in security environments |
CN113158982A (zh) * | 2021-05-17 | 2021-07-23 | 广东中卡云计算有限公司 | 一种半介入式的目标关键点标注方法 |
JP7368679B2 (ja) * | 2021-09-01 | 2023-10-25 | イミュニティリサーチ株式会社 | 細胞集団同定システム、方法、およびプログラム |
IT202200001817A1 (it) | 2022-02-02 | 2023-08-02 | Aizoon S R L | Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico |
IT202200005861A1 (it) | 2022-03-24 | 2023-09-24 | Aizoon S R L | Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico |
US20240028964A1 (en) | 2022-07-25 | 2024-01-25 | Aizoon S.r.l. | Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6463438B1 (en) * | 1994-06-03 | 2002-10-08 | Urocor, Inc. | Neural network for cell image analysis for identification of abnormal cells |
US5740269A (en) * | 1994-09-20 | 1998-04-14 | Neopath, Inc. | Method and apparatus for robust biological specimen classification |
US6996549B2 (en) * | 1998-05-01 | 2006-02-07 | Health Discovery Corporation | Computer-aided image analysis |
US6282305B1 (en) * | 1998-06-05 | 2001-08-28 | Arch Development Corporation | Method and system for the computerized assessment of breast cancer risk |
US6337472B1 (en) * | 1998-10-19 | 2002-01-08 | The University Of Texas System Board Of Regents | Light imaging microscope having spatially resolved images |
WO2002059377A2 (en) * | 2001-01-24 | 2002-08-01 | Protein Design Labs | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
EP1525450A2 (en) * | 2002-07-30 | 2005-04-27 | Deutsches Krebsforschungszentrum | Method and apparatus for multiple labeling detection and evaluation of a plurality of particles |
US20040121413A1 (en) * | 2002-12-20 | 2004-06-24 | Aebersold Rudolf H. | Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions |
US20050265588A1 (en) * | 2004-02-03 | 2005-12-01 | Bioimagene, Inc. | Method and system for digital image based flourescent in situ hybridization (FISH) analysis |
US20060275844A1 (en) * | 2005-04-19 | 2006-12-07 | Linke Steven P | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
US8041090B2 (en) * | 2005-09-10 | 2011-10-18 | Ge Healthcare Uk Limited | Method of, and apparatus and computer software for, performing image processing |
US7933435B2 (en) * | 2005-11-21 | 2011-04-26 | Vala Sciences, Inc. | System, method, and kit for processing a magnified image of biological material to identify components of a biological object |
WO2007136724A2 (en) * | 2006-05-17 | 2007-11-29 | Cellumen, Inc. | Method for automated tissue analysis |
US7741045B2 (en) * | 2006-11-16 | 2010-06-22 | General Electric Company | Sequential analysis of biological samples |
US8019134B2 (en) * | 2006-11-16 | 2011-09-13 | Definiens Ag | Automatic image analysis and quantification for fluorescence in situ hybridization |
US20100178653A1 (en) * | 2007-03-27 | 2010-07-15 | Rosetta Genomics Ltd. | Gene expression signature for classification of cancers |
CA2683134A1 (en) * | 2007-05-07 | 2008-11-13 | Ge Healthcare Bio-Sciences Corp. | System and method for the automated analysis of cellular assays and tissues |
WO2008143849A2 (en) * | 2007-05-14 | 2008-11-27 | Historx, Inc. | Compartment segregation by pixel characterization using image data clustering |
CA2698569A1 (en) * | 2007-09-06 | 2009-09-03 | Mark G. Erlander | Tumor grading and cancer prognosis |
US9779213B2 (en) * | 2008-07-25 | 2017-10-03 | Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud | System for evaluating a pathological stage of prostate cancer |
ES2795036T3 (es) * | 2008-07-25 | 2020-11-20 | Fund D Anna Sommer Champalimaud E Dr Carlos Montez Champalimaud | Sistemas y métodos para tratar, diagnosticar y predecir la aparición de una afección médica |
US20110091081A1 (en) * | 2009-10-16 | 2011-04-21 | General Electric Company | Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin |
US8320655B2 (en) | 2009-10-16 | 2012-11-27 | General Electric Company | Process and system for analyzing the expression of biomarkers in cells |
WO2011087778A1 (en) * | 2009-12-22 | 2011-07-21 | The Children's Hospital Of Philadelphia | Automated quantitative multidimensional volumetric analysis and visualization |
-
2011
- 2011-10-03 US US13/252,078 patent/US20120269419A1/en not_active Abandoned
- 2011-10-03 US US13/252,072 patent/US20120269418A1/en not_active Abandoned
- 2011-10-03 US US13/252,080 patent/US20120271553A1/en not_active Abandoned
- 2011-10-03 US US13/252,069 patent/US20120270752A1/en not_active Abandoned
-
2012
- 2012-04-23 SG SG2013078738A patent/SG194592A1/en unknown
- 2012-04-23 SG SG2013078753A patent/SG194594A1/en unknown
- 2012-04-23 RU RU2013145154/15A patent/RU2013145154A/ru not_active Application Discontinuation
- 2012-04-23 EP EP12716027.3A patent/EP2700036A2/en not_active Withdrawn
- 2012-04-23 CA CA2833428A patent/CA2833428A1/en not_active Abandoned
- 2012-04-23 JP JP2014505669A patent/JP6063446B2/ja active Active
- 2012-04-23 EP EP12717662.6A patent/EP2700038B1/en active Active
- 2012-04-23 BR BR112013027125A patent/BR112013027125A2/pt not_active IP Right Cessation
- 2012-04-23 BR BR112013027122A patent/BR112013027122A2/pt not_active IP Right Cessation
- 2012-04-23 WO PCT/EP2012/057394 patent/WO2012143561A2/en unknown
- 2012-04-23 SG SG2013078712A patent/SG194590A1/en unknown
- 2012-04-23 WO PCT/EP2012/057390 patent/WO2012143558A2/en unknown
- 2012-04-23 EP EP12716028.1A patent/EP2700037A2/en not_active Withdrawn
- 2012-04-23 CA CA2833804A patent/CA2833804A1/en not_active Abandoned
- 2012-04-23 SG SG2013078688A patent/SG194588A1/en unknown
- 2012-04-23 EP EP12719316.7A patent/EP2700042B1/en active Active
- 2012-04-23 BR BR112013027123A patent/BR112013027123A2/pt not_active IP Right Cessation
- 2012-04-23 CA CA2833497A patent/CA2833497A1/en not_active Abandoned
- 2012-04-23 RU RU2013145162/15A patent/RU2013145162A/ru not_active Application Discontinuation
- 2012-04-23 WO PCT/EP2012/057395 patent/WO2012143562A2/en unknown
- 2012-04-23 RU RU2013145151/15A patent/RU2013145151A/ru not_active Application Discontinuation
- 2012-04-23 JP JP2014505668A patent/JP6163152B2/ja active Active
- 2012-04-23 CA CA2833295A patent/CA2833295A1/en not_active Abandoned
- 2012-04-23 JP JP2014505671A patent/JP6063447B2/ja active Active
- 2012-04-23 WO PCT/EP2012/057387 patent/WO2012143556A2/en unknown
- 2012-04-23 JP JP2014505670A patent/JP6143743B2/ja active Active
- 2012-04-23 BR BR112013027124A patent/BR112013027124A2/pt not_active IP Right Cessation
-
2014
- 2014-03-05 US US14/197,558 patent/US20140185905A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013027123A2 (pt) | método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células | |
Steyerberg | Validation in prediction research: the waste by data splitting | |
Konrad et al. | Epithelial–mesenchymal transition in endometriosis—when does it happen? | |
Jayawardana et al. | Determination of prognosis in metastatic melanoma through integration of clinico‐pathologic, mutation, mRNA, microRNA, and protein information | |
Young et al. | The identification of tuberculosis biomarkers in human urine samples | |
JP2014517954A5 (pt) | ||
Peng et al. | Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer | |
BR112013009008A2 (pt) | métodos e kits para a detecção de células circulantes de tumor em pacientes pancreáticos com o uso de reagentes de detecção de captura e de coquetel poliespecíficos | |
BR112013003391B8 (pt) | Método para diagnosticar câncer pancreático em um indivíduo | |
BR112014006432A2 (pt) | biomarcadores do câncer de pulmão e seus usos | |
BR112016002435A2 (pt) | proteínas biomarcadoras da síndrome urêmica hemolítica atípica | |
BRPI0811607A8 (pt) | Modelagem de diagnóstico remoto | |
Ware et al. | Biomarkers of ARDS: what’s new? | |
WO2012061515A3 (en) | Methods of classifying human subjects with regard to cancer prognosis | |
BR112014029233A8 (pt) | método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio | |
EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
BR112014031182A2 (pt) | método para testar uma formação, sistema para testar a pressão de uma formação e meio de armazenamento legível por computador | |
BR112014011563A2 (pt) | métodos para detectar o papiloma-vírus humano e fornecer o prognóstico para carci-noma de células escamosas de cabeça e pescoço | |
Xu et al. | Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients | |
Sweeney et al. | Multicohort analysis of whole-blood gene expression data does not form a robust diagnostic for acute respiratory distress syndrome | |
Damluji et al. | Short-term mortality prediction for acute lung injury patients: external validation of the Acute Respiratory Distress Syndrome Network prediction model | |
Mulder et al. | Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study | |
BR112014030243A2 (pt) | métodos para diagnosticar doença valvular crônica | |
Vaida et al. | Identifying Robust Biomarker Panels for Breast Cancer Screening | |
LI | Application of an interim18F-FDG PET/CT interpretation method for evaluating the prognosis of diffuse large B-cell lymphoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |